Intracin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 04-01-2025
- Paid Up Capital ₹ 5.48 M
as on 04-01-2025
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.82 Cr
as on 04-01-2025
- Satisfied Charges ₹ 9.80 M
as on 04-01-2025
- Revenue 18.33%
(FY 2021)
- Profit 74.63%
(FY 2021)
- Ebitda 72.19%
(FY 2021)
- Net Worth 37.04%
(FY 2021)
- Total Assets 9.36%
(FY 2021)
About Intracin Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.48 M.
The company currently has active open charges totaling ₹10.82 Cr. The company has closed loans amounting to ₹9.80 M, as per Ministry of Corporate Affairs (MCA) records.
Brijeshbhai Desai and Shaileshbhai Desai serve as directors at the Company.
- CIN/LLPIN
U24231GJ1994PTC022070
- Company No.
022070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationNadiad, Gujarat
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Intracin Pharmaceuticals Private Limited offer?
Intracin Pharmaceuticals Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Intracin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijeshbhai Desai  | Director | 31-Mar-2004 | Current |
| Shaileshbhai Desai | Director | 17-May-1994 | Current |
Financial Performance of Intracin Pharmaceuticals.
Intracin Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 18.33% increase. The company also saw a substantial improvement in profitability, with a 74.63% increase in profit. The company's net worth Soared by an impressive increase of 37.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intracin Pharmaceuticals?
In 2021, Intracin Pharmaceuticals had a promoter holding of 37.01% and a public holding of 62.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jul 2019 | ₹10.82 Cr | Open |
Others Creation Date: 06 Aug 2004 | ₹8.00 M | Satisfied |
The Janta Co.Op.Bank Ltd Creation Date: 27 May 2000 | ₹1.80 M | Satisfied |
How Many Employees Work at Intracin Pharmaceuticals?
Unlock and access historical data on people associated with Intracin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intracin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intracin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
